CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project seeks to develop a non-antibiotic treatment for Clostridium difficile infection using modified fecal bacteriotherapy. The approach involves creating capsules containing processed colonic flora to restore gut health.
We wish to exploit the need for effective treatment for nosocomial diarrhoea especially that caused by Clostridium difficiledisease (CDD).
Patients treated with broad spectrum antibiotics are at greatest risk of CDD diarrhoea and many of thoseaffected are hospitalised elderly patients with serious underlying illnesses.
Antibiotics can cause disruption of the normalintestinal flora, an important part of the immune system, leading to an overgrowth of CDD.
Currently, some 2350 patientssuffering fro…
PNO CONSULTANTS LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, SALE
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Romania, TIMISOARA TIMIS
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Italy, Rome
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
United Kingdom, BROMSGROVE
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
